These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 10480306)
1. Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis. Yoshida T; Koga H; Saitoh F; Sakamoto M; Harada M; Yoshida H; Sakisaka S; Sata M Intern Med; 1999 Sep; 38(9):733-8. PubMed ID: 10480306 [TBL] [Abstract][Full Text] [Related]
2. Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis. Tanaka F; Origuchi T; Migita K; Tominaga M; Kawakami A; Kawabe Y; Eguchi K Intern Med; 2000 May; 39(5):428-30. PubMed ID: 10830189 [TBL] [Abstract][Full Text] [Related]
3. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis. Yamasaki Y; Yamada H; Yamasaki M; Ohkubo M; Azuma K; Matsuoka S; Kurihara Y; Osada H; Satoh M; Ozaki S Rheumatology (Oxford); 2007 Jan; 46(1):124-30. PubMed ID: 16754626 [TBL] [Abstract][Full Text] [Related]
4. A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis. Mira-Avendano IC; Parambil JG; Yadav R; Arrossi V; Xu M; Chapman JT; Culver DA Respir Med; 2013 Jun; 107(6):890-6. PubMed ID: 23517887 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of steroid-resistant polymyositis and dermatomyositis]. Mimura T; Kanda H; Kubo K Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154 [TBL] [Abstract][Full Text] [Related]
6. [Pulmonary damage during polymyositis and dermatomyositis: interstitial lung disease]. Marie I; Dominique S Presse Med; 2006 Apr; 35(4 Pt 2):683-95. PubMed ID: 16614615 [TBL] [Abstract][Full Text] [Related]
7. [Successful therapy with cyclosporine in a case with interstitial pneumonitis associated with polymyositis]. Soga T; Hagiwara E; Shirai A; Igarashi T; Ishigatsubo Y; Okubo T Nihon Rinsho Meneki Gakkai Kaishi; 1996 Apr; 19(2):157-62. PubMed ID: 8705693 [TBL] [Abstract][Full Text] [Related]
8. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis? Maeda K; Kimura R; Komuta K; Igarashi T Scand J Rheumatol; 1997; 26(1):24-9. PubMed ID: 9057798 [TBL] [Abstract][Full Text] [Related]
9. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940 [TBL] [Abstract][Full Text] [Related]
10. Interstitial lung disease due to polymyositis or dermatomyositis: effect of a 6-month course of i.v. pulse cyclophosphamide. Meyer O; Hayem G; Palazzo E; Crestani B; Debray MP; Ballard M Clin Exp Rheumatol; 2005; 23(5):724. PubMed ID: 16173257 [No Abstract] [Full Text] [Related]
11. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Schnabel A; Reuter M; Biederer J; Richter C; Gross WL Semin Arthritis Rheum; 2003 Apr; 32(5):273-84. PubMed ID: 12701038 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867 [TBL] [Abstract][Full Text] [Related]
13. Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy. Shinohara T; Hidaka T; Matsuki Y; Ishizuka T; Takamizawa M; Kawakami M; Kikuma H; Suzuki K; Nakamura H Intern Med; 1997 Jul; 36(7):519-23. PubMed ID: 9240505 [TBL] [Abstract][Full Text] [Related]
15. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726 [TBL] [Abstract][Full Text] [Related]
16. [Successful treatment of interstitial pneumonia and pneumomediastinum associated with polymyositis during pregnancy with a combination of cyclophosphamide and tacrolimus: A case report]. Okada R; Miyabe YS; Kasai S; Hashimoto K; Yamauchi S; Yoshikawa M; Sumori K; Nagasaka K Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(3):142-8. PubMed ID: 20601834 [TBL] [Abstract][Full Text] [Related]
17. Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine. Mok CC; To CH; Szeto ML Scand J Rheumatol; 2003; 32(3):181-3. PubMed ID: 12892257 [TBL] [Abstract][Full Text] [Related]
18. Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis. Shimojima Y; Ishii W; Matsuda M; Kishida D; Ikeda SI J Clin Rheumatol; 2017 Mar; 23(2):87-93. PubMed ID: 28225510 [TBL] [Abstract][Full Text] [Related]
19. [Pulmonary involvements in patients with collagen disease]. Endo H Nihon Rinsho; 2009 Mar; 67(3):536-41. PubMed ID: 19280929 [TBL] [Abstract][Full Text] [Related]
20. [Interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases]. Bartosiewicz M; Siemion-Szcześniak I; Sobiecka M; Wyrostkiewicz D; Radwan-Röhrenschef P; Lewandowska K; Langfort R; Oniszh K; Franczuk M; Kuś J Pneumonol Alergol Pol; 2013; 81(6):556-66. PubMed ID: 24142786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]